-
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Moderate Buy" by Brokerages
来源: Buzz FX / 01 1月 2025 03:41:14 America/Chicago
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat January 1, 2025 Share Link copied to clipboard. Shares of 4D Molecular Therapeutics, Inc.
Read more...